Daily Stock Opinions and Ratings

Opinions

Kash Pashootan KP Tissue Inc KPT-T WATCH May 17, 2018

Consumer staples. He was taking a look at it when it pulled back He stayed away because the chart is telling him there is no clarity on share price given that input costs are on the rise. It is too early to buy.

Kash Pashootan

Unlock Rating

$10.160

Stock price when the opinion was issued

Consumer Products

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

HOLD

This company produces paper towels and other paper products. The rising cost for pulp has hurt their bottom line. China is buying more pure pulp fibre and this is hurting their business. Yield 7.4%. (Analysts’ price target is $11.00)

DON'T BUY

A down trend with resistance at $10. It could move back up, but there's nowhere to hang your hat on this chart. There's no base in the price.

WATCH

Is the dividend safe? He doesn't know, but they have many troubles lately with low pulp prices and writedowns. The 8.7% yield isn't exactly safe. They're building a new plant in Sherbrooke to improve profitability. Hang onto it, but watch if that dividend rises.

WATCH

It bottomed in November and flat lined. It has resistance at $8.66 and the fact that we are through it is pretty positive. Watch to see if it holds and if it gets above the moving average. It's at a pretty critical juncture.

WATCH

Since early august we had a more parabolic move up. We want to keep that on trend so in a corrective move you want it to stay on the trajectory.

DON'T BUY

A small-cap that owns an interest in tissue paper, a commodity. Pays a high dividend but also high payout, so a strong risk of a dividend cut. How long can they sustain that dividend and how deep will they cut it?

WATCH

He owned this in the past. The stock has really picked up last year. The problem is that it has no power over the input price. They have made a bet in building a plant in Quebec and the balance sheet is stressed.

HOLD

A good stable share price but mediocre on price momentum and valuation.

DON'T BUY

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

KPT is a $101.6M company that pays a high yield of 7.1%. Its valuation is decent, but its balance sheet has been contracting for several years now. It's considered a consumer staples name, but we are not very impressed by the fundamentals or financials. Decent growth is expected over the next two years, but we would probably wait to see if fundamentals materially improve before investing here, given its negative momentum and contracting fundamentals.
Unlock Premium - Try 5i Free

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Kash Pashootan KP Tissue Inc KPT-T WATCH May 17, 2018

You might be interested:

KP Tissue Inc(KPT-T)

KP Tissue Inc(KPT-T)

KP Tissue Inc(KPT-T)

KP Tissue Inc(KPT-T)

KP Tissue Inc(KPT-T)

KP Tissue Inc(KPT-T)

KP Tissue Inc(KPT-T)

KP Tissue Inc(KPT-T)

KP Tissue Inc(KPT-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Bruce Murray

The Weekly Buzzing Stocks by Billy Kawasaki

Chris Blumas

Stockchase Insights

Jim Cramer - Mad Money